Telix Reports Positive Phase III Meeting with the FDA
Filed with ASX · · 4 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Telix and Monrol Manufacturing and Distribution Agreement
- Telix and Osaka University Extend Collaboration
- Prostate Imaging Program - Commercial and Regulatory Update
- Appendix 4C - March 2019 Quarter
- Fractionated Prostate Cancer Therapy Published
Later from Telix Pharmaceuticals
- Telix announces completion of $40.0 million Placement
- Investor Presentation
- Telix Receives $9.3m R&D Tax Refund
- Appendix 4C - June 2019 Quarter
- Sales Note to Accompany June 2019 Quarter Appendix 4C
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals